The targeting construct introduced into exon 1 a loxP site, splice acceptor, H2B-Cherry reporter gene, triple stop polyadenylation sequence, loxP site and FRT site. Flpo-recombination removed the FRT-flanked neomycin resistance cassette to leave the single FRT site. (J:226395)